Lumos Diagnostics Holdings Limited
LDXHF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 78.61% | 37.62% | 5.66% | -12.27% | -28.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.61% | 37.62% | 5.66% | -12.27% | -28.67% |
| Cost of Revenue | 42.58% | 9.55% | -14.03% | -44.96% | -61.60% |
| Gross Profit | 108.43% | 63.15% | 24.92% | 55.85% | 145.98% |
| SG&A Expenses | 5.29% | 2.46% | -0.33% | -23.44% | -37.98% |
| Depreciation & Amortization | -9.02% | -18.67% | -26.61% | -24.23% | -21.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.44% | -0.19% | -9.53% | -31.56% | -45.27% |
| Operating Income | 45.30% | 35.14% | 25.17% | 44.82% | 54.02% |
| Income Before Tax | 43.50% | 23.70% | 4.22% | 65.29% | 78.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.50% | 23.70% | 4.22% | 65.29% | 78.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.50% | 23.70% | 4.22% | 65.29% | 78.59% |
| EBIT | 45.30% | 35.14% | 25.17% | 44.82% | 54.02% |
| EBITDA | 53.95% | 38.21% | 21.48% | 48.57% | 59.81% |
| EPS Basic | 61.02% | 55.94% | 52.97% | 85.61% | 90.77% |
| Normalized Basic EPS | 72.00% | 64.49% | 59.31% | 71.96% | 76.30% |
| EPS Diluted | 61.02% | 55.94% | 53.09% | 85.62% | 90.77% |
| Normalized Diluted EPS | 72.00% | 64.49% | 59.31% | 71.96% | 76.30% |
| Average Basic Shares Outstanding | 55.48% | 72.19% | 97.24% | 95.51% | 93.29% |
| Average Diluted Shares Outstanding | 55.48% | 72.19% | 97.24% | 95.51% | 93.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
